|Scoping workshop:||18 March 2013|
|Consultation on draft scope with stakeholders:||10 April - 8 May 2013|
|Consultation on draft guideline with stakeholders:||28 January 2015 - 11 March 2015|
|Developer||National Clinical Guideline Centre|
|09 May 2016||7 primary care sites across England have been recruited to the asthma - diagnosis and monitoring guideline primary care implementation feasibility project. They will implement the recommended diagnostic pathway and collect data for the 6 month period May-October 2016.|
|25 January 2016||NICE is now seeking expressions of interest from general practice sites for the asthma - diagnosis and monitoring guideline primary care implementation feasibility project. The deadline for submission is 27 February 2016. Please see the project page https://www.nice.org.uk/about/nice-communities/general-practice/asthma-primary-care-project for further details. This page will be updated regularly as the project progresses.|
|20 January 2016||Interim findings of the Guideline Committee are available on this website, (see ‘Project documents’ ). The Adoption and Impact programme are planning an implementation feasibility project in a variety of primary care settings which use different asthma service delivery models. The project will focus on the impact and feasibility of implementing 2 of the objective tests (quality-assured spirometry and fractional exhaled nitric oxide [FeNO]), which are recommended in the different diagnosis algorithms of the proposed guideline. NICE will be seeking expressions of interest from general practice sites in January 2016. The project will run for a 6 month period April – November 2016. Further details will be made available as the project progresses.|
|20 January 2016||Interim findings|
|14 January 2016||Guideline finalisation|
|11 August 2015||
The NICE guideline on asthma diagnosis and monitoring will be delayed until later this year. This is to allow additional time to work with commissioners and healthcare professionals in asthma care to make sure the recommendations can be introduced effectively and efficiently.
The guideline proposes some radical and innovative changes with considerable benefits for patients and the NHS as a whole, but we accept this will be challenging to introduce. Smooth implementation of this guideline will help millions of adults, children and young people get the right diagnosis and better control their asthma symptoms as well as offer considerable savings to the NHS and beyond.
The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. The Health Economic plan, review questions and search strategies will be available on the website 5 weeks prior to consultation commencing.
|7 June 2013||
The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process.
Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply.
The National Collaborating Centre and the Institute are in the process of agreeing details of the workplan including how the development will progress, the membership of the Guideline Development Group and timescales.
|10 April - 8 May 2013||
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
The NCC is currently looking to recruit members for the Guideline Development Group (GDG).
|7 September 2012||The remit was received from the Department of Health and the Welsh Government in August 2012.|
For further information on the guideline development process, please read how we develop NICE guidelines